secwatch.observer — SEC 8-K summary
======================================

Issuer:     FMC CORP (FMC)
CIK:        0000037785
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0000037785-26-000083
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FMC Q1 net loss $281M, Adj EBITDA $72M above guidance; reaffirms FY outlook
---------------------------------------------------------------------------

- Revenue $759M (-4% YoY); GAAP EPS $(2.25); adj EPS $(0.23); adj EBITDA $72M (-40%).
- Board-authorized strategic alternatives evaluation (since Feb 2026) progressing; no transaction assured.
- FY 2026 guidance reaffirmed: rev $3.6-3.8B, adj EBITDA $670-730M, adj EPS $1.63-1.89, FCF -$65M to $65M.
- Q2 2026 view: rev $850-900M, adj EBITDA $130-150M, adj EPS $0.16-0.26.
- New active ingredient sales doubled YoY; Plant Health grew 6%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/37785/000003778526000083/0000037785-26-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/37785/000003778526000083/fmc-20260429.htm
  HTML page:      https://secwatch.observer/filing/0000037785-26-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer